Public Employees Retirement Association of Colorado raised its position in shares of Hologic Inc. (NASDAQ:HOLX) by 0.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 451,970 shares of the company’s stock after buying an additional 1,070 shares during the period. Public Employees Retirement Association of Colorado owned 0.16% of Hologic worth $15,638,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Panagora Asset Management Inc. increased its position in Hologic by 247.3% in the first quarter. Panagora Asset Management Inc. now owns 1,682,853 shares of the company’s stock worth $58,058,000 after buying an additional 1,198,338 shares in the last quarter. AMP Capital Investors Ltd increased its position in Hologic by 33.8% in the first quarter. AMP Capital Investors Ltd now owns 222,865 shares of the company’s stock worth $7,690,000 after buying an additional 56,357 shares in the last quarter. Schonfeld Strategic Advisors LLC purchased a new position in Hologic during the first quarter worth approximately $689,000. Oakbrook Investments LLC purchased a new position in Hologic during the second quarter worth approximately $907,000. Finally, Geode Capital Management LLC increased its position in Hologic by 54.3% in the first quarter. Geode Capital Management LLC now owns 2,328,326 shares of the company’s stock worth $80,187,000 after buying an additional 819,646 shares in the last quarter. Hedge funds and other institutional investors own 94.51% of the company’s stock.

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Shares of Hologic Inc. (NASDAQ:HOLX) traded up 0.39% during trading on Wednesday, hitting $38.84. The company had a trading volume of 620,259 shares. Hologic Inc. has a 12-month low of $31.84 and a 12-month high of $41.66. The stock has a market cap of $10.78 billion, a PE ratio of 42.82 and a beta of 1.00. The firm has a 50 day moving average of $38.49 and a 200 day moving average of $36.30.

Hologic (NASDAQ:HOLX) last released its quarterly earnings data on Wednesday, July 27th. The company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.03. Hologic had a return on equity of 26.25% and a net margin of 9.39%. The company had revenue of $717.40 million for the quarter, compared to analyst estimates of $703.66 million. During the same period in the prior year, the company posted $0.43 EPS. The company’s revenue was up 3.4% compared to the same quarter last year. On average, analysts forecast that Hologic Inc. will post $1.94 earnings per share for the current fiscal year.

A number of research analysts have commented on the company. Piper Jaffray Cos. set a $44.00 target price on Hologic and gave the stock a “hold” rating in a report on Sunday, August 28th. Needham & Company LLC reissued a “hold” rating on shares of Hologic in a report on Thursday, July 28th. BTIG Research reissued a “buy” rating and issued a $44.00 price target on shares of Hologic in a report on Thursday, July 28th. Jefferies Group raised their price target on Hologic from $42.00 to $43.00 and gave the stock a “buy” rating in a report on Thursday, July 28th. Finally, Morgan Stanley raised their price target on Hologic from $38.00 to $40.00 and gave the stock an “equal weight” rating in a report on Thursday, July 28th. Six investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $42.71.

In other news, Director Nancy Leaming sold 8,179 shares of the business’s stock in a transaction that occurred on Thursday, July 21st. The stock was sold at an average price of $37.00, for a total value of $302,623.00. Following the transaction, the director now directly owns 67,140 shares of the company’s stock, valued at approximately $2,484,180. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.84% of the stock is owned by insiders.

Hologic Company Profile

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Its Diagnostics products include its Aptima family of assays, which run on its advanced instrumentation systems (Panther and Tigris); ThinPrep system; the Rapid Fetal Fibronectin Test, and Procleix blood screening assays.

5 Day Chart for NASDAQ:HOLX

Receive News & Stock Ratings for Hologic Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic Inc. and related stocks with our FREE daily email newsletter.